EUVIMEDEUVIMED entdecken
Crossref

Resveratrol targets mitochondrial USP36–SOD2 to induce autophagy-ferroptosis and inhibit gastric cancer progression

Xuan Zhao, Sheng Lu, Min Yan, Zheng-Gang Zhu, Feng Dong, Chao Yan iD

Gastric Cancer · 2025-11 · 28 (6) · 1067-1084

DOI: 10.1007/s10120-025-01645-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastric Cancer, online erschienen am 12.07.2025. Verfasst von Xuan Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin Er Road, Shanghai, 200025, China. Hauptthemen laut MEDLINE: Resveratrol, Stomach Neoplasms, Autophagy, Superoxide Dismutase. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Guangci Innovative Technology Launch Plan of Ruijin Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gastric cancer is an aggressive malignancy with high metastatic potential, limiting effective treatments. Resveratrol, a natural polyphenol, exhibits anti-cancer properties by modulating mitochondrial function and inducing programmed cell death (PCD) pathways. However, its role in mitochondrial disruption and the regulation of deubiquitination remains unclear. METHODS: Clinical samples and gastric cancer cell lines were analyzed to assess USP36 and SOD2 expression. Cells were treated with resveratrol, followed by functional assays (WB, qPCR, colony formation, Transwell migration, fluorescence staining) to evaluate its effects on USP36-mediated SOD2 stabilization, mitochondrial function, autophagy, and ferroptosis. A xenograft model was used to examine in vivo tumor growth. RESULTS: USP36 deubiquitinates and stabilizes SOD2, thereby preserving mitochondrial integrity and facilitating tumor progression. Resveratrol disrupts this axis, reducing SOD2 stability, inducing mitochondrial dysfunction, and triggering autophagy and ferroptosis. In vitro, resveratrol significantly inhibited gastric cancer cell proliferation and migration; in vivo, it suppressed tumor growth. CONCLUSION: This study identifies the USP36-SOD2 axis as a critical driver of gastric cancer progression and reveals the therapeutic potential of resveratrol in targeting this pathway. By destabilizing mitochondrial function, resveratrol induces both autophagy and ferroptosis, thereby suppressing tumor progression and offering a promising strategy to improve clinical outcomes. Resveratrol inhibits USP36-mediated stabilization of SOD2, which further induces autophagy and ferroptosis by inducing mitochondrial damage and ROS accumulation, and suppressing tumor progression in a xenograft model. These findings underscore the USP36-SOD2 axis as a potential therapeutic target and highlight the adjunctive chemotherapeutic potential of resveratrol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolStomach NeoplasmsAutophagySuperoxide DismutaseFerroptosisMitochondriaUbiquitin ThiolesteraseHumansAnimalsMiceXenograft Model Antitumor AssaysDisease ProgressionMice, NudeCell Line, TumorCell ProliferationCell MovementSuperoxide Dismutase 2

Stichwörter der Autor:innen

Gastric cancerMitochondrial damageResveratrolSOD2USP36

Substanzen

ResveratrolSuperoxide DismutaseUbiquitin ThiolesteraseSuperoxide Dismutase 2

Autor:innen und Institutionen

  • Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin Er Road, Shanghai, 200025, China.
  • Shanghai Minimally Invasive Surgery Center, Shanghai, China.
  • Shanghai Institute of Digestive Surgery, Shanghai, 200025, China.
  • Shanghai Key Laboratory of Stomach Neoplasm, Shanghai, 200025, China.
  • Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin Er Road, Shanghai, 200025, China. doctoryc@yeah.net.
  • Shanghai Institute of Digestive Surgery, Shanghai, 200025, China. doctoryc@yeah.net.

ORCID-Profile: Chao Yan

Förderung

  • Guangci Innovative Technology Launch Plan of Ruijin Hospital

Zitieren

APA

Zhao, X., Lu, S., Yan, M., Zhu, Z. G., Dong, F., & Yan, C. (2025). Resveratrol targets mitochondrial USP36–SOD2 to induce autophagy-ferroptosis and inhibit gastric cancer progression. Gastric Cancer, 28(6), 1067-1084. https://doi.org/10.1007/s10120-025-01645-3

Vancouver

Zhao X, Lu S, Yan M, Zhu ZG, Dong F, Yan C. Resveratrol targets mitochondrial USP36–SOD2 to induce autophagy-ferroptosis and inhibit gastric cancer progression. Gastric Cancer. 2025;28(6):1067-1084. doi:10.1007/s10120-025-01645-3

BibTeX
@article{Zhao2025,
  author = {Zhao, Xuan and Lu, Sheng and Yan, Min and Zhu, Zheng-Gang and Dong, Feng and Yan, Chao},
  title = {Resveratrol targets mitochondrial USP36–SOD2 to induce autophagy-ferroptosis and inhibit gastric cancer progression},
  journal = {Gastric Cancer},
  year = {2025},
  volume = {28},
  number = {6},
  pages = {1067--1084},
  doi = {10.1007/s10120-025-01645-3}
}
Kostenlos starten →